Best practice for hypertensive patients with kidney disease.
Many patients with non-diabetic and diabetic renal disease undergo chronic renal function loss leading to dialysis or renal transplantation. The US National Kidney Foundation guidelines recommend that angiotensin-converting enzyme inhibitors and angiotensin type receptor antagonists are first choice therapy for these patients.
de Zeeuw
Dick
D
Department of Clinical Pharmacology, University of Groningen, Ant Deusingglaan 1, 9713 AV Groningen, The Netherlands.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D017281:Cost of Illness; D003922:Diabetes Mellitus, Type 1 / Q000628:therapy; D003924:Diabetes Mellitus, Type 2 / Q000628:therapy; D003928:Diabetic Nephropathies / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000517:prevention & control*; D017410:Practice Guidelines as Topic
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents